Tuesday
Dec212010
GeneKey Announces Launch
Tuesday, December 21, 2010 at 2:32PM
GeneKey is a new company designed to implement and scale the personalized oncology services piloted by CollabRx ONE. Under the scientific leadership of former CollabRx ONE principal Raphael Lehrer, Ph.D., GeneKey will deliver an enhanced version of CollabRx's patient-focused services. In addition, the company will continue to develop the technology, focusing on advancing its tumor analysis capabilities, cost reductions (including automation), launching clinical trials with key investigators in various types of cancer and establishing relationships with treatment centers.
Reader Comments